Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000906358) titled 'A study of chemotherapy with or without OncoSil™ targeted radiation treatment for people with locally advanced pancreatic cancer' on July 23.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Primary Sponsor: Royal Adelaide Hospital
Condition:
Unresectable Locally Advanced Pancreatic Adenocarcinoma
Unresectable Locally Advanced Pancreatic Adenocarcinoma
Cancer - Pancreatic
Intervention:
The substance being investigated for the project is an active implantable (radiological) medical device called OncoSil, which contai...